Sutimlimab, a complement C1s inhibitor, improves quality of life in patients with cold agglutinin disease: Patient-reported outcomes results of the phase 3 cardinal study

被引：0

作者：

Roeth, A. ^{[1
]}

Barcellini, W. ^{[2
]}

Tvedt, Anderson T. H. ^{[3
]}

Miyakawa, Y. ^{[4
]}

Kuter, D. J. ^{[5
]}

Hobbs, W. ^{[6
]}

Su, J. ^{[6
]}

Jiang, X. ^{[6
]}

Arias, Morales J. ^{[6
]}

Weitz, I. C. ^{[7
]}

机构：

[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol, West German Canc Ctr, Essen, Germany

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[3] Haukeland Hosp, Sect Hematol, Dept Med, Bergen, Norway

[4] Saitama Med Univ Hosp, Ctr Thrombosis & Hemostasis, Saitama, Japan

[5] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol, Boston, MA 02115 USA

[6] Sanofi, Cambridge, MA USA

[7] Univ Southern Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Dept Med, Los Angeles, CA 90007 USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

246

引用

页码：179 / 180

页数：2

共 50 条

[21] Sustained Complement C1s Inhibition with Sutimlimab in Patients with Cold Agglutinin Disease Results in Continued Efficacy during Part B of the Randomized Placebo-Controlled Phase 3 Cadenza Study (NCT03347422)
Roeth, Alexander
Berentsen, Sigbjorn
Barcellini, Wilma
D'Sa, Shirley
Jilma, Bernd
Michel, Marc
Weitz, Ilene C.
Yamaguchi, Masaki
Nishimura, Jun-ichi
Vos, Josephine M., I
Cid, Joan
Storek, Michael
Wong, Nancy
Yoo, Ronnie
Wang, Jennifer
Vagge, Deepthi
Wardecki, Marek
Shafer, Frank
Lee, Michelle
Broome, Catherine M.
[J]. BLOOD, 2022, 140 : 2825 - 2827
[22] Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B
Roeth, Alexander
Berentsen, Sigbjorn
Barcellini, Wilma
D'Sa, Shirley
Jilma, Bernd
Michel, Marc
Weitz, Ilene C.
Yamaguchi, Masaki
Nishimura, Jun-ichi
Vos, Josephine M. I.
Cid, Joan
Storek, Michael
Wong, Nancy
Yoo, Ronnie
Jayawardene, Deepthi
Srivastava, Shruti
Wardecki, Marek
Shafer, Frank
Lee, Michelle
Broome, Catherine M.
[J]. ECLINICALMEDICINE, 2024, 74
[23] Sustained complement C1s inhibition with sutimlimab in patients with cold agglutinin disease results in continued efficacy during part B of the randomized placebo-controlled phase 3 CADENZA study (NCT03347422)
Roeth, Alexander
Berentsen, Sigbjorn
Barcellini, Wilma
D'Sa, Shirley
Jilma, Bernd
Michel, Marc
Weitz, Ilene C.
Yamaguchi, Masaki
Nishimura, Jun-ichi
Vos, Josephine M. I.
Cid, Joan
Storek, Michael
Wong, Nancy
Yoo, Ronnie
Wang, Jennifer
Vagge, Deepthi S.
Wardecki, Marek
Shafer, Frank
Lee, Michelle
Broome, Catherine M.
[J]. IMMUNOBIOLOGY, 2023, 228 (05) : 10 - 10
[24] Sustained complement C1s inhibition with sutimlimab in patients with cold agglutinin disease results in continued efficacy during part B of the randomized placebo-controlled phase 3 CADENZA study (NCT03347422)
Roeth, A.
Berentsen, S.
Barcellini, W.
D'Sa, S.
Jilma, B.
Michel, M.
Weitz, I. C.
Yamaguchi, M.
Nishimura, J., I
Vos, J. M.
Cid, J.
Storek, M.
Wong, N.
Yoo, R.
Wang, J.
Vagge, D. S.
Wardecki, M.
Shafer, F.
Lee, M.
Broome, C. M.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 120 - 120
[25] Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program
Gelbenegger, Georg
Schoergenhofer, Christian
Derhaschnig, Ulla
Buchtele, Nina
Sillaber, Christian
Fillitz, Michael
Schenk, Thomas M.
D'Sa, Shirley
Cartwright, Ronwyn
Gilbert, James C.
Jilma, Bernd
Jaeger, Ulrich
[J]. BLOOD ADVANCES, 2020, 4 (06) : 997 - 1005
[26] Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up
Roeth, Alexander
Broome, Catherine M.
Barcellini, Wilma
Tvedt, Tor Henrik Anderson
Miyakawa, Yoshitaka
D'Sa, Shirley
Cella, David
Bozzi, Sylvie
Jayawardene, Deepthi
Yoo, Ronnie
Shafer, Frank
Wardecki, Marek
Weitz, Ilene C.
[J]. BLOOD ADVANCES, 2023, 7 (19) : 5890 - 5897
[27] Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension
Roeth, Alexander
Broome, Catherine M.
Barcellini, Wilma
Jilma, Bernd
Hill, Quentin A.
Cella, David
Tvedt, Tor Henrik Anderson
Yamaguchi, Masaki
Murakhovskaya, Irina
Lee, Michelle
Shafer, Frank
Wardecki, Marek
Jayawardene, Deepthi
Yoo, Ronnie
Msihid, Jerome
Weitz, Ilene C.
[J]. ECLINICALMEDICINE, 2024, 74
[28] Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
Jaeger, Ulrich
D'Sa, Shirley
Schoergenhofer, Christian
Bartko, Johann
Derhaschnig, Ulla
Sillaber, Christian
Jilma-Stohlawetz, Petra
Fillitz, Michael
Schenk, Thomas
Patou, Gary
Panicker, Sandip
Parry, Graham C.
Gilbert, James C.
Jilma, Bernd
[J]. BLOOD, 2019, 133 (09) : 893 - 901
[29] C1s-targeted inhibition of classical complement pathway by sutimlimab in cold agglutinin disease (CAD): Efficacy and safety results from the randomized, placebo (PBO)-controlled phase 3 CADENZA study
Roth, A.
Berentsen, S.
Barcellini, W.
D'Sa, S.
Jilma, B.
Michel, M.
Weitz, I. C.
Yamaguchi, M.
Nishimura, J., I
Vos, J. M., I
Patel, P.
Schaible, B.
Jiang, X.
Vagge, D. S.
Wardecki, M.
Shafer, F.
Lee, M.
Broome, C. M.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 40 - 41
[30] Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up (Vol 7, pg 5890, 2023)
Roth, A.
Broome, C. M.
Barcellini, W.
[J]. BLOOD ADVANCES, 2024, 8 (11) : 2650 - 2650

← 1 2 3 4 5 →